Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-21 · accession 0001610717-26-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-01-23 | 2026-01-21 | RVMD | Cislini Jeff | GC | S - Sale | $115.60 | -908 | 47.0K | -2% | -$105.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-21 | S | D | 908 | $115.60 | 46,976 | D | — | — | (F2) Includes 38,769 restricted stock units. |